Homoeriodictyol

Synonyms: 高圣草酚
Homoeriodictyol 是一种具有口服活性且可穿透血脑屏障的苦味掩盖黄烷酮,它通过 NCOA4 介导的铁蛋白自噬 (autophagy) 增强突触相关蛋白表达,通过抑制 NLRP3 炎症小体改善小鼠的记忆障碍,通过激活 Nrf2 和抑制线粒体功能障碍保护人类内皮细胞免受氧化损伤,通过增强 ROS 活性诱导细胞凋亡 (apoptosis) 表现出抗癌作用,在体外抑制雄激素耐药前列腺癌细胞的存活和迁移,并在小鼠体内发挥抗伤害感受活性。
产品编号: MS-L65686 纯度: 99.86% CAS No.: 446-71-9 分子式: C16H14O6 分子量: 302.28
MolStrong 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
规格 价格 是否有货 数量 购物车
10mM * 1mL in DMSO
询价
3-5 天
1mg
询价
3-5 天
5mg
询价
3-5 天
10mg
询价
3-5 天
50mg
询价
询价
100mg
询价
询价

产品描述

Homoeriodictyol 是一种具有口服活性且可穿透血脑屏障的苦味掩盖黄烷酮,它通过 NCOA4 介导的铁蛋白自噬 (autophagy) 增强突触相关蛋白表达,通过抑制 NLRP3 炎症小体改善小鼠的记忆障碍,通过激活 Nrf2 和抑制线粒体功能障碍保护人类内皮细胞免受氧化损伤,通过增强 ROS 活性诱导细胞凋亡 (apoptosis) 表现出抗癌作用,在体外抑制雄激素耐药前列腺癌细胞的存活和迁移,并在小鼠体内发挥抗伤害感受活性。

生物实验数据

生物活性 Homoeriodictyol is an orally active, blood-brain barrier-permeable bitter-masking flavanone that enhances synapse-related protein expression via NCOA4-mediated ferritinophagy (autophagy), ameliorates memory impairment in mice by inhibiting the NLRP3 inflammasome, protects human endothelial cells from oxidative damage by activating Nrf2 and inhibiting mitochondrial dysfunction, exhibits anticancer effects by enhancing ROS activity to induce apoptosis (apoptosis), inhibits the survival and migration of androgen-resistant prostate cancer cells in vitro, and exerts antinociceptive activity in mice.
IC50 & Target

Caspase 3

 

Caspase-9

 

体外研究
(In Vitro)

Homoeriodictyol (0.1-1 μM) 在 Corticosterone (MS-F46715) 诱导的 SH-SY5Y 细胞中,可提高细胞活力、PSD-95、SYN、P62 和 FTH 水平,并降低 LC3 和 NCOA4 水平。
Homoeriodictyol (10 μM/L,24 小时) 在 N9 小胶质细胞中可恢复细胞活力和迁移水平,并降低炎症因子水平。
Homoeriodictyol (0-20 μM,16 小时) 可上调 MDA-MB-231 细胞中 Nrf2 和 γGCS 的蛋白水平。
Homoeriodictyol (1-5 μM,12-24 小时) 在 H2O2 诱导的 EA.hy926 细胞中可预防线粒体功能障碍和细胞凋亡,降低 MMP、细胞色素 C、tAIF、裂解胱天蛋白酶-3、-9 和 PARP 的水平。
Homoeriodictyol (0-5 μM,2-24 小时) 在 EA.hy926 细胞中通过在蛋白质水平诱导 Nrf2 并增强 Nrf2 的稳定性来激活 Nrf2 通路。
Homoeriodictyol (100-500 μg/mL,24 小时) 在 MCF-7、HeLa 和 HT-29 细胞中表现出细胞毒性和浓度依赖性溶酶体毒性,增强细胞内 ROS 生成,并诱导线粒体功能障碍。
Homoeriodictyol (500 μg/mL, 24 小时) 在 MCF-7、HeLa 和 HT-29 细胞中可增加 subG1 峰,并增加 p53、caspase 3、caspase 9、bax 和 SOD1 基因的表达。
Homoeriodictyol (0-250 μM, 24-72 小时) 可降低 PC3 细胞的细胞活力,IC50 为 118.15 μM,诱导细胞凋亡,抑制 PC3 细胞的细胞迁移。

ELISA Assay

Cell Line: N9 microglial cells
Concentration: 10 μM/L
Incubation Time: 24 h
Result: Reduced levels of IL-1β and IL-18.

Cell Migration Assay

Cell Line: N9 microglial cells
Concentration: 10 μM/L
Incubation Time: 24 h
Result: Restored migration levels.

Western Blot Analysis

Cell Line: MDA-MB-231 cells
Concentration: 0, 2.5, 5,10, 20 μM
Incubation Time: 16 h
Result: Upregulated the protein levels of Nrf2 and γGCS.

Apoptosis Analysis

Cell Line: H2O2-induced EA.hy926 cells
Concentration: 2, 5 μM
Incubation Time: 24 h
Result: Decreased apoptosis cells.

Immunofluorescence

Cell Line: EA.hy926 cells
Concentration: 2, 5 μM
Incubation Time: 12 h
Result: Activated the nuclear translocation of Nrf2 protein.

Western Blot Analysis

Cell Line: EA.hy926 cells
Concentration: 1, 2, 5 μM
Incubation Time: 2, 4, 6, 8, 12, 16 h
Result: Activated the nuclear translocation of Nrf2 protein.
Increased protein levels of Nrf2, NQO1, and γGCS, continued to increase Nrf2 protein levels over the 24 hours tested.

RT-PCR

Cell Line: EA.hy926 cells
Concentration: 1, 2, 5 μM
Incubation Time: 24 h
Result: Did not affect mRNA level of Nrf2, but upregulated the levels of NQO1 and GCLM.

Immunofluorescence

Cell Line: H2O2-induced EA.hy926 cells
Concentration: 2, 5 μM
Incubation Time: 12 h
Result: Reduce MMP levels.
Reduced cytochrome C protein levels in the cytoplasm and mitochondria.
Inhibited tAIF production and blocks AIF translocation from mitochondria to the nucleus.

Western Blot Analysis

Cell Line: H2O2-induced EA.hy926 cells
Concentration: 1, 2, 5 μM
Incubation Time: 12 h
Result: Reduced cytochrome C protein levels in the cytoplasm and mitochondria.
Inhibited tAIF production and blocks AIF translocation from mitochondria to the nucleus.
Inhibited H2O2-induced activations of cleaved caspases -3, -9 and PARP.

Immunofluorescence

Cell Line: MCF-7, HeLa, and HT-29 cells
Concentration: 500 μg/mL
Incubation Time: 24 h
Result: Increased the green fluorescence of DCF, increased the fluorescence of Rh123 fluorescence.

Cell Cycle Analysis

Cell Line: MCF-7, HeLa, and HT-29 cells
Concentration: 500 μg/mL
Incubation Time: 24 h
Result: Increased the subG1 peaks.

RT-PCR

Cell Line: MCF-7, HeLa, and HT-29 cells
Concentration: 100 μg/mL
Incubation Time: 24 h
Result: Increased the expressions of p53, caspase 3, caspase 9, bax, and SOD1 genes.

Apoptosis Analysis

...(内容过长已截断)
Cell Line: PC3 cells
Concentration: PC3 cells
Incubation Time: 72 h
Result:
体内研究
(In Vivo)

Homoeriodictyol (10 mg/kg/d,口服,4 周) 通过抑制 NLRP3 炎症小体来减轻阿尔茨海默症昆明小鼠模型中的炎症,从而改善 Aβ25-35 诱导的记忆障碍。
Homoeriodictyol (50 μg/kg,腹腔注射,一次) 在瑞士白化小鼠模型中通过中枢和外周通路表现出抗伤害活性。

Animal Model: Aβ25-35-induced AD kunming mice (Male, 7 weeks old) model
Dosage: 10 mg/kg/d
Administration: p.o., 4 weeks
Result: Improved memory impairment and cognitive dysfunction, alleviated hippocampal neuronal damage.
Decreased the levels of Aβ1-40, Aβ1-42, and p-Tau in the hippocampus.
Reduced oxidative stress in the brain, reduced the levels of ROS, apoptosis and MDA, increased the levels of GSH-Px and SOD.
Resulted in increased numbers of NK cells, Th cells, Tc cells, and DCs, and decreased numbers of MDSCs and Treg cells in peripheral blood and splenic tissues.
Had excellent anti-inflammatory effects, reduced the protein expression levels of NLRP3, Caspase-1, and ASC, and the inflammatory factors IL-18 and IL-1β in brain tissue.
Animal Model: Swiss albino mice (adult male, 24-28 g) model
Dosage: 50, 100, 150, and 200 μg/kg
Administration: i.p., once
Result: Lowered the writhing responses to acetic acid, showed a dose-responsive relation analgesic effect.
Increased the time respond to thermal pain on a hot plate.
Decreased the licking times in both the early and late phases after formalin injection, alleviated pain in the formalin test.
Lessened licking time after Capsaicin (MS-R45786) injection, indicating a dose-responsive effect.
Reduced paw licking times, mitigated glutamate-induced pain responses.
Clinical Trial
NCT NumberSponsorConditionStart DatePhase
NCT07573787Christoph Grimm|University of Vienna
Gynecologic Cancers
2021-03-15NA
NCT02372188University of Vienna
Change of Gastric pH
2013-09NA
性状 固体
颜色 White to off-white

化学信息

分子量 302.28
分子式 C16H14O6
CAS No. 446-71-9
别名 高圣草酚

储存&溶解度

储存方式

4°C, protect from light

*In solvent: -80°C, 6 months; -20°C, 1 month (protect from light)

运输条件 Room temperature in continental US; may vary elsewhere.
溶液配制表

DMSO 中的溶解度 : 50 mg/mL (165.41 mM; 超声助溶; 吸湿的 DMSO 对产品的溶解度有显著影响,请使用新开封的 DMSO)

可选溶剂浓度1 mg5 mg10 mg25 mg
DMSO1 mM3.3082 mL16.5410 mL33.0819 mL82.7048 mL
5 mM0.6616 mL3.3082 mL6.6164 mL16.5410 mL
10 mM0.3308 mL1.6541 mL3.3082 mL8.2705 mL
15 mM0.2205 mL1.1027 mL2.2055 mL5.5137 mL
20 mM0.1654 mL0.8270 mL1.6541 mL4.1352 mL
25 mM0.1323 mL0.6616 mL1.3233 mL3.3082 mL
30 mM0.1103 mL0.5514 mL1.1027 mL2.7568 mL
40 mM0.0827 mL0.4135 mL0.8270 mL2.0676 mL
50 mM0.0662 mL0.3308 mL0.6616 mL1.6541 mL
60 mM0.0551 mL0.2757 mL0.5514 mL1.3784 mL
80 mM0.0414 mL0.2068 mL0.4135 mL1.0338 mL
100 mM0.0331 mL0.1654 mL0.3308 mL0.8270 mL

* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month (protect from light)。-80°C储存时,请在6个月内使用,-20°C储存时,请在1个月内使用。

该溶液配制表仅适用于固体产品。对于液体产品,请根据标明的浓度或密度计算稀释方案。

高圣草酚 相关分类

计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
起始浓度(M)× 起始体积(L)= 最终浓度(M)× 最终体积(L)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
溶液体积 = 质量 ÷ 配液浓度
Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration
÷
分子量计算器
Enter the chemical formula of the compound to calculate its molar mass and elemental composition
g/mol

体内实验配液计算器

动物实验计算换算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:

比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL, 一共给药动物10只,您使用的配方为 10% DMSO + 40% PEG300 + 5% Tween 80 + 45% Saline / PBS / ddH2O, 那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 100 μL DMSO ( 母液浓度为 20 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法: 取 100 μL DMSO 母液, 添加 400 μL PEG300 混匀澄清, 再加 50 μL Tween 80, 混匀澄清, 再加 450 μL Saline / PBS / ddH2O 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

方案所需的各类助溶剂如: DMSO, PEG300, PEG400, Tween 80, SBE-β-CD, 玉米油等, 均可在MolStrong网站点击购买。

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系客服为您提供正确的澄清溶液配方)
+
+
+

计算结果:

工作液浓度: mg/ml;

DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,

体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL Saline/PBS/ddH2O,混匀澄清。

1. 首先保证母液是澄清的;
           2. 一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础

  • 客服

    2851296953

    18923798467

    微信洽谈